Commercialization Readiness Programs. DoD Commercialization Readiness Pilot is made permanent and includes the STTR program; Commercialization Readiness Pilot programs for civilian agencies are authorized allowing agencies to use up to 10% of SBIR/STTR funds to support commercialization and Phase III efforts.

Stay tuned. NIH is considering a Commercialization Readiness Program.

Phase III preference. Agencies directed to support SBIR/STTR awardees in their efforts to commercialize SBIR/STTR work through, among other things, Phase III sole-source contracts.

NIH is not typically the purchaser of products developed with SBIR and STTR funds. This is most commonly done by the Department of Defense. In those rare cases where NIH might purchase, NIH will support Phase III sole-source contracts.